Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Kim K, Pröbstel AK, Baumann R, Dyckow J, Landefeld J, Kogl E, Madireddy L, Loudermilk R, Eggers EL, Singh S, Caillier SJ, Hauser SL, Cree BAC; UCSF MS-EPIC Team, Schirmer L, Wilson MR, Baranzini SE.